stockportfolio.pro
Stocks / NRC vs OVID
NRC vs OVID
NRC Health and Ovid Therapeutics Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
| NRC Health (NRC) | Ovid Therapeutics Inc. (OVID) | |
|---|---|---|
| Market cap | $0.4B | $0.4B |
| Revenue (latest FY) | $137.39M | $7.25M |
| Net income (latest FY) | $11.60M | $-17.41M |
| Revenue growth (5y CAGR) | 0.6% | -10.5% |
| Net margin | 8.4% | -240.1% |
| Return on equity | 82.9% | -13.3% |
| P/E ratio | 49.5 | — |
| Dividend yield | 2.8% | — |
| Profitable years (of last 10) | 10 | 1 |
| Positive free cash flow | Yes | No |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open NRC — free Open OVID — freeFrequently asked questions
Which is bigger, NRC or OVID?
NRC Health is larger by market capitalization — $0.4B versus $0.4B.
Which grows faster, NRC or OVID?
Over the last five fiscal years, NRC Health grew revenue faster — 0.6%/yr versus -10.5%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.